Literature DB >> 15507607

De novo initiation pocket mutations have multiple effects on hepatitis C virus RNA-dependent RNA polymerase activities.

C T Ranjith-Kumar1, R T Sarisky, L Gutshall, M Thomson, C C Kao.   

Abstract

The hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) has several distinct biochemical activities, including initiation of RNA synthesis by a de novo mechanism, extension from a primed template, nontemplated nucleotide addition, and synthesis of a recombinant RNA product from two or more noncovalently linked templates (template switch). All of these activities require specific interaction with nucleoside triphosphates (NTPs). Based on the structure of the HCV RdRp bound to NTP (S. Bressanelli, L. Tomei, F. A. Rey, and R. DeFrancesco, J. Virol. 76:3482-3492, 2002), we mutated the amino acid residues that contact the putative initiation GTP and examined the effects on the various activities. Although all mutations retained the ability for primer extension, alanine substitution at R48, R158, R386, R394, or D225 decreased de novo initiation, and two or more mutations abolished de novo initiation. While the prototype enzyme had a K(m) for GTP of 3.5 microM, all of the mutations except one had K(m)s that were three- to sevenfold higher. These results demonstrate that the affected residues are functionally required to interact with the initiation nucleotide. Unexpectedly, many of the mutations also affected the addition of nontemplated nucleotide, indicating that residues in the initiating NTP (NTPi)-binding pocket are required for nontemplated nucleotide additions. Interestingly, mutations in D225 are dramatically affected in template switch, indicating that this residue of the NTPi pocket also interacts with components in the elongation complex. We also examined the interaction of ribavirin triphosphate with the NTPi-binding site.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507607      PMCID: PMC525054          DOI: 10.1128/JVI.78.22.12207-12217.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Factors regulating template switch in vitro by viral RNA-dependent RNA polymerases: implications for RNA-RNA recombination.

Authors:  M J Kim; C Kao
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

Review 2.  De novo initiation of viral RNA-dependent RNA synthesis.

Authors:  C C Kao; P Singh; D J Ecker
Journal:  Virology       Date:  2001-09-01       Impact factor: 3.616

3.  Roles of histidine 784 and tyrosine 639 in ribose discrimination by T7 RNA polymerase.

Authors:  L G Brieba; R Sousa
Journal:  Biochemistry       Date:  2000-02-08       Impact factor: 3.162

4.  Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.

Authors:  A M Di Bisceglie; J Thompson; N Smith-Wilkaitis; E M Brunt; B R Bacon
Journal:  Hepatology       Date:  2001-03       Impact factor: 17.425

5.  Coupling ribose selection to fidelity of DNA synthesis. The role of Tyr-115 of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  C E Cases-Gonzalez; M Gutierrez-Rivas; L Ménendez-Arias
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

6.  The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen.

Authors:  S Crotty; D Maag; J J Arnold; W Zhong; J Y Lau; Z Hong; R Andino; C E Cameron
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

Review 7.  Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon: A meta-analysis of randomized trials.

Authors:  K J Cummings; S M Lee; E S West; J Cid-Ruzafa; S G Fein; Y Aoki; M S Sulkowski; S N Goodman
Journal:  JAMA       Date:  2001-01-10       Impact factor: 56.272

8.  Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.

Authors:  G L Davis; R Esteban-Mur; V Rustgi; J Hoefs; S C Gordon; C Trepo; M L Shiffman; S Zeuzem; A Craxi; M H Ling; J Albrecht
Journal:  N Engl J Med       Date:  1998-11-19       Impact factor: 91.245

9.  Terminal nucleotidyl transferase activity of recombinant Flaviviridae RNA-dependent RNA polymerases: implication for viral RNA synthesis.

Authors:  C T Ranjith-Kumar; J Gajewski; L Gutshall; D Maley; R T Sarisky; C C Kao
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

10.  Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli.

Authors:  E Ferrari; J Wright-Minogue; J W Fang; B M Baroudy; J Y Lau; Z Hong
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more
  15 in total

1.  Efficient in vitro system of homologous recombination in brome mosaic bromovirus.

Authors:  Rafal Wierzchoslawski; Jozef J Bujarski
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

2.  Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes.

Authors:  Catherine A Lázaro; Ming Chang; Weiliang Tang; Jean Campbell; Daniel G Sullivan; David R Gretch; Lawrence Corey; Robert W Coombs; Nelson Fausto
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

3.  Screening of the yeast yTHC collection identifies essential host factors affecting tombusvirus RNA recombination.

Authors:  Elena Serviene; Yi Jiang; Chi-Ping Cheng; Jannine Baker; Peter D Nagy
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 4.  Mechanistic cross-talk between DNA/RNA polymerase enzyme kinetics and nucleotide substrate availability in cells: Implications for polymerase inhibitor discovery.

Authors:  Si'Ana A Coggins; Bijan Mahboubi; Raymond F Schinazi; Baek Kim
Journal:  J Biol Chem       Date:  2020-07-31       Impact factor: 5.157

5.  Substrate recognition by norovirus polymerase: microsecond molecular dynamics study.

Authors:  Kamil Maláč; Ivan Barvík
Journal:  J Comput Aided Mol Des       Date:  2013-04-26       Impact factor: 3.686

6.  Identification of a structural element of the hepatitis C virus minus strand RNA involved in the initiation of RNA synthesis.

Authors:  Kathleen Mahias; Neveen Ahmed-El-Sayed; Cyril Masante; Juliette Bitard; Cathy Staedel; Fabien Darfeuille; Michel Ventura; Thérèse Astier-Gin
Journal:  Nucleic Acids Res       Date:  2010-03-01       Impact factor: 16.971

7.  A locking mechanism regulates RNA synthesis and host protein interaction by the hepatitis C virus polymerase.

Authors:  Sreedhar Chinnaswamy; Ian Yarbrough; Satheesh Palaninathan; C T Ranjith Kumar; Vinodhini Vijayaraghavan; Borries Demeler; Stanley M Lemon; James C Sacchettini; C Cheng Kao
Journal:  J Biol Chem       Date:  2008-04-28       Impact factor: 5.157

8.  Evidence for Internal Initiation of RNA Synthesis by the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B In Cellulo.

Authors:  Philipp Schult; Maren Nattermann; Chris Lauber; Stefan Seitz; Volker Lohmann
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

9.  Recombinant viral RdRps can initiate RNA synthesis from circular templates.

Authors:  C T Ranjith-Kumar; C C Kao
Journal:  RNA       Date:  2005-12-22       Impact factor: 4.942

Review 10.  Structures of hepatitis C virus nonstructural proteins required for replicase assembly and function.

Authors:  Meigang Gu; Charles M Rice
Journal:  Curr Opin Virol       Date:  2013-04-16       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.